|
1
|
Ball HJ, Melnick A, Shaknovich R, Kohanski
RA and Licht JD: The promyelocytic leukemia zinc finger (PLZF)
protein binds DNA in a high molecular weight complex associated
with cdc2 kinase. Nucleic Acids Res. 27:4106–4113. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Suliman BA, Xu D and Williams BR: The
promyelocytic leukemia zinc finger protein: Two decades of
molecular oncology. Front Oncol. 2:742012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi WI, Kim MY, Jeon BN, Koh DI, Yun CO,
Li Y, Lee CE, Oh J, Kim K and Hur MW: Role of promyelocytic
leukemia zinc finger (PLZF) in cell proliferation and
cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) gene
repression. J Biol Chem. 289:18625–18640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Felicetti F, Errico MC, Bottero L,
Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini
M, Colombo MP, et al: The promyelocytic leukemia zinc
finger-microRNA-221/-222 pathway controls melanoma progression
through multiple oncogenic mechanisms. Cancer Res. 68:2745–2754.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vincent A, Omura N, Hong SM, Jaffe A,
Eshleman J and Goggins M: Genome-wide analysis of promoter
methylation associated with gene expression profile in pancreatic
adenocarcinoma. Clin Cancer Res. 17:4341–4354. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsuzawa K, Izawa S, Ohkura T, Ohkura H,
Ishiguro K, Yoshida A, Takiyama Y, Haneda M, Shigemasa C, Yamamoto
K, et al: Implication of intracellular localization of
transcriptional repressor PLZF in thyroid neoplasms. BMC Endocr
Disord. 14:522014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hsieh CL, Botta G, Gao S, Li T, Van Allen
EM, Treacy DJ, Cai C, He HH, Sweeney CJ, Brown M, et al: PLZF, a
tumor suppressor genetically lost in metastatic
castration-resistant prostate cancer, is a mediator of resistance
to androgen deprivation therapy. Cancer Res. 75:1944–1948. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hui AW, Lau HW, Cao CY, Zhou JW, Lai PB
and Tsui SK: Downregulation of PLZF in human hepatocellular
carcinoma and its clinical significance. Oncol Rep. 33:397–402.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao GQ, Li F, Findeis-Hosey J, Hyrien O,
Unger PD, Xiao L, Dunne R, Kim ES, Yang Q, McMahon L, et al:
Down-regulation of cytoplasmic PLZF correlates with high tumor
grade and tumor aggression in non-small cell lung carcinoma. Hum
Pathol. 46:1607–1615. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin Y, Nenseth HZ and Saatcioglu F: Role
of PLZF as a tumor suppressor in prostate cancer. Oncotarget.
8:71317–71324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen H, Zhan M, Zhang Y, Huang S, Xu S,
Huang X, He M, Yao Y, Man M and Wang J: PLZF inhibits proliferation
and metastasis of gallbladder cancer by regulating IFIT2. Cell
Death Dis. 9:712018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jones C, St-Jean S, Fréchette I, Bergeron
D, Rivard N and Boudreau F: Identification of a novel promyelocytic
leukemia zinc-finger isoform required for colorectal cancer cell
growth and survival. Int J Cancer. 133:58–66. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine
27 by polycomb CBX7 in transcriptional silencing of INK4a.
Mol Cell. 38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pasmant E, Laurendeau I, Héron D, Vidaud
M, Vidaud D and Bièche I: Characterization of a germ-line deletion,
including the entire INK4/ARF locus, in a melanoma-neural
system tumor family: Identification of ANRIL, an antisense
noncoding RNA whose expression coclusters with ARF. Cancer
Res. 67:3963–3969. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen S, Zhang JQ, Chen JZ, Chen HX, Qiu
FN, Yan ML, Chen YL, Peng CH, Tian YF and Wang YD: The over
expression of long non-coding RNA ANRIL promotes
epithelial-mesenchymal transition by activating the ATM-E2F1
signaling pathway in pancreatic cancer: An in vivo and in vitro
study. Int J Biol Macromol. 102:718–728. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of
p15INK4B tumor suppressor gene. Oncogene. 30:1956–1962.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Hevi S, Kurash JK, Lei H, Gay F,
Bajko J, Su H, Sun W, Chang H, Xu G, et al: The lysine demethylase
LSD1 (KDM1) is required for maintenance of global DNA methylation.
Nat Genet. 41:125–129. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Li C, Zhang R, Xiao W, Niu X, Ye X,
Li Z, Guo Y, Tan J and Li Y: The EZH2- H3K27me3-DNMT1 complex
orchestrates epigenetic silencing of the wwc1 gene, a
Hippo/YAP pathway upstream effector, in breast cancer epithelial
cells. Cell Signal. 51:243–256. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Long HK, King HW, Patient RK, Odom DT and
Klose RJ: Protection of CpG islands from DNA methylation is
DNA-encoded and evolutionarily conserved. Nucleic Acids Res.
44:6693–6706. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nawaz I, Qiu X, Wu H, Li Y, Fan Y, Hu LF,
Zhou Q and Ernberg I: Development of a multiplex methylation
specific PCR suitable for (early) detection of non-small cell lung
cancer. Epigenetics. 9:1138–1148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen JF, Wu P, Xia R, Yang J, Huo XY, Gu
DY, Tang CJ, De W and Yang F: STAT3-induced lncRNA HAGLROS
overexpression contributes to the malignant progression of gastric
cancer cells via mTOR signal-mediated inhibition of autophagy. Mol
Cancer. 17:62018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang F, Deng R, Qian XJ, Chang SH, Wu XQ,
Qin J, Feng GK, Ding K and Zhu XF: Feedback loops blockade
potentiates apoptosis induction and antitumor activity of a novel
AKT inhibitor DC120 in human liver cancer. Cell Death Dis.
5:e11142014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marchese FP and Huarte M: Long non-coding
RNAs and chromatin modifiers: Their place in the epigenetic code.
Epigenetics. 9:21–26. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cech TR and Steitz JA: The noncoding RNA
revolution-trashing old rules to forge new ones. Cell. 157:77–94.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang MD, Chen WM, Qi FZ, Xia R, Sun M, Xu
TP, Yin L, Zhang EB, De W and Shu YQ: Long non-coding RNA ANRIL is
upregulated in hepatocellular carcinoma and regulates cell
apoptosis by epigenetic silencing of KLF2. J Hematol Oncol.
8:502015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Colquhoun A, Arnold M, Ferlay J, Goodman
KJ, Forman D and Soerjomataram I: Global patterns of cardia and
non-cardia gastric cancer incidence in 2012. Gut. 64:1881–1888.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chia NY, Deng N, Das K, Huang D, Hu L, Zhu
Y, Lim KH, Lee MH, Wu J, Sam XX, et al: Regulatory crosstalk
between lineage-survival oncogenes KLF5GATA4GATA6
cooperatively promotes gastric cancer development. Gut. 64:707–719.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thiem S, Eissmann MF, Elzer J, Jonas A,
Putoczki TL, Poh A, Nguyen P, Preaudet A, Flanagan D, Vincan E, et
al: Stomach-specific activation of oncogenic KRAS and
STAT3-dependent inflammation cooperatively promote gastric
tumorigenesis in a preclinical model. Cancer Res. 76:2277–2287.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang K, Liang Q, Li X, Tsoi H, Zhang J,
Wang H, Go MY, Chiu PW, Ng EK, Sung JJ and Yu J: MDGA2 is a novel
tumour suppressor cooperating with DMAP1 in gastric cancer and is
associated with disease outcome. Gut. 65:1619–1631. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang X, Wang L, Guo S, Bao Y, Ma Y, Yan F,
Xu K, Xu Z, Jin L, Lu D, et al: Hypermethylation reduces expression
of tumor-suppressor PLZF and regulates proliferation and apoptosis
in non-small-cell lung cancers. FASEB J. 27:4194–4203. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Felicetti F, Bottero L, Felli N, Mattia G,
Labbaye C, Alvino E, Peschle C, Colombo MP and Carè A: Role of PLZF
in melanoma progression. Oncogene. 23:4567–4576. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nguyen CT, Gonzales FA and Jones PA:
Altered chromatin structure associated with methylation-induced
gene silencing in cancer cells: Correlation of accessibility,
methylation, MeCP2 binding and acetylation. Nucleic Acids Res.
29:4598–4606. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ombrato L and Malanchi I: The EMT
universe: Space between cancer cell dissemination and metastasis
initiation. Crit Rev Oncog. 19:349–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
